GT Biopharma (GTBP)
(Delayed Data from NSDQ)
$3.35 USD
-0.41 (-10.84%)
Updated Apr 26, 2024 03:13 PM ET
After-Market: $3.21 -0.14 (-4.04%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth C Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/20/2024
Time: -- |
3/2024 | $-2.70 | 0.00% |
Earnings Summary
For their last quarter, GT Biopharma (GTBP) reported earnings of -$1.80 per share, beating the Zacks Consensus Estimate of $-3.00 per share. This reflects a positive earnings surprise of 40.00%. Look out for GTBP's next earnings release expected on May 20, 2024. For the next earning release, we expect the company to report earnings of -$2.70 per share, reflecting a year-over-year decrease of 12.5%.
Earnings History
Price & Consensus
Zacks News for GTBP
Here's Why GT Biopharma, Inc. (GTBP) Is a Great 'Buy the Bottom' Stock Now
GTBP: What are Zacks experts saying now?
Zacks Private Portfolio Services